Treatment of gastric outlet obstruction that results from unresectable gastric cancer: Current evidence

Table 2 Patient demographics and main results in two reviews

Ref.	Study type	Procedure		Performance status		Comparison between GJ and ESregarding several variables
		GJ	ES	GJ	ES	Toleration of oral intake	GOO recurrence	Time to oral intake	Hospital stay	Complication
Fiori et al[53]	Prospective	9 (LGJ 0)	9	NR	NR	GJ is approximately equal to ES	GJ (0%) < ES (33%)a	GJ (6.3 d)	GJ (10 d)	GJ: SSI, bleeding, ventral hernia
								ES (3.1 d)	ES (4.8 d)	ES: Stent dislocation, re-obstruction
No et al[54]	Retrospective	41 (LGJ 9)	72	0-11: 68.3%	0-11: 59.7%	GJ (95.1%) is approximately equal to ES (87.5%)	GJ (12.2%) < ES (44.4%)a	GJ (16 d) > ES (10 d)a	GJ (18 d) > ES (16 d)3	GJ is approximately equal to ES
				21: 31.7%	21: 40.3%
Keränen et al[55]	Retrospective	21 (LGJ 0)	50	I-II2: 90.5%	I-II2: 58%	GJ (81%) is approximately equal to ES (88%)	GJ (9.5%)	GJ (4 d) > ES (1 d)a	GJ (8 d) > ES (3 d)a	GJ (10%)
				III-IV2: 9.5%	III-IV2: 42%		ES (24%)			ES (26%)

¹ECOG performance status;

²WHO score;

³Not significant;

^aP < 0.05. GJ: Gastrojejunostomy; ES: Endoscopic stenting; LGJ: Laparoscopic GJ; NR: Not reported; ECOG: Eastern Cooperative Oncology Group; WHO: World Health Organization.